California Resources Corp Positioned for Growth With Aera Deal and CCS Project Advancement: Buy Rating Affirmed
Analysts Offer Insights on Energy Companies: Excelerate Energy, Inc. Class A (EE), Matador Resources (MTDR) and CNX Resources (CNX)
Mizuho Securities Sticks to Its Hold Rating for Gulfport Energy (GPOR)
CrossFirst Bankshares (CFB) Receives a Buy From KBW
KBW Sticks to Their Hold Rating for FB Financial (FBK)
Buy Rating Maintained for Beacon Roofing Supply Amidst Market Resilience and Positive Industry Indicators
Analysts Are Bullish on These Healthcare Stocks: Madrigal Pharmaceuticals (MDGL), Benitec Biopharma (BNTC)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Progyny (PGNY) and Nanosonics Limited (OtherNNCSF)
Analysts' Opinions Are Mixed on These Healthcare Stocks: KalVista Pharmaceuticals (KALV), Roche Holding AG (OtherRHHVF) and Pfizer (PFE)
Accel Entertainment's Growth Trajectory Strengthened by Strategic Fairmount Holdings Acquisition
Morgan Stanley Cuts STAAR to Underweight, Cites Growth Expectations
Bloom Energy's Bright Outlook: Buy Rating Affirmed Amid New Amazon Deal and Clean Tech Sector Potential
Wedbush Raises Price Target on Revolution Medicines to $59 From $46, Maintains Outperform Rating
Mirum Pharmaceuticals (MIRM) Gets a Buy From JMP Securities
Optimistic Buy Rating for Revolution Medicines' RMC-6236 Amid Favorable Clinical Data and Strategic Management Decisions
New York Community Analyst Ratings
Embecta Analyst Ratings
Nevro Analyst Ratings
IRhythm Technologies Analyst Ratings
Integra Lifesciences Analyst Ratings